Baifuzi reduces transient ischemic brain damage through an interaction with the STREX domain of BKCa channels

Cell Death and Disease

Volumn 1, Issue 1, 2010, Pages

  Chi, S ^a,c   Cai, W ^b   Liu, P ^c,e   Zhang, Z ^b   Chen, X ^c   Gao, L ^d   Qi, J ^d   Bi, L ^c   Chen, L ^b   Qi, Z ^a,c  

^a XIAMEN UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF BIOPHYSICS   (China)

^d ZHEJIANG UNIVERSITY   (China)

^e UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Baifuzi; BKCa channel; brain ischemia; cerebroside; traditional Chinese medicine

Indexed keywords

ALCOHOL; BAIFUZI; CALCIUM ACTIVATED POTASSIUM CHANNEL; CEREBROSIDE; CHINESE DRUG; PROTEIN STREX; UNCLASSIFIED DRUG; GLUTAMIC ACID; HERBACEOUS AGENT; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNIT; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG TARGETING; EXON; GENE DELETION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PURIFICATION; RAT; TRANSIENT ISCHEMIC ATTACK; ANIMAL; BRAIN ISCHEMIA; CHEMISTRY; MALE; METABOLISM; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SPRAGUE DAWLEY RAT;

MUS; RATTUS; TYPHONIUM GIGANTEUM;

ANIMALS; BRAIN ISCHEMIA; DRUGS, CHINESE HERBAL; GLUTAMIC ACID; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; MALE; MICE; NEUROPROTECTIVE AGENTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79251534670     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2009.10     Document Type: Article

References (58)

1. Shuaib A, Hussain MS. The past and future of neuroprotection in cerebral ischaemic stroke. Eur Neurol 2008; 59: 4-14. (Pubitemid 350277253)
2. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008; 371: 1612-1623. (Pubitemid 351626845)
3. Gladstone DJ, Black SE, Hakim AM. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 2002; 33: 2123-2136. (Pubitemid 34840080)
4. Corson TW, Crews CM. Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell 2007; 130: 769-774. (Pubitemid 47332575)
5. Chen ST, Dou J, Temple R, Agarwal R, Wu KM, Walker S. New therapies from old medicines. Nat Biotechnol 2008; 26: 1077-1083.
6. Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov 2005; 4: 206-220. (Pubitemid 40372555)
7. Sucher NJ. Insights from molecular investigations of traditional Chinese herbal stroke medicines: implications for neuroprotective epilepsy therapy. Epilepsy Behav 2006; 8: 350-362. (Pubitemid 43231227)
8. Hansen AJ, Nedergaard M. Brain ion homeostasis in cerebral ischemia. Neurochem Pathol 1988; 9: 195-209. (Pubitemid 19164804)
9. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22: 391-397. (Pubitemid 29453643)
10. Knaus HG, Schwarzer C, Koch RO, Eberhart A, Kaczorowski G, Glossmann H et al. Distribution of high-conductance Ca 2+-activated K+channels in rat brain: targeting to axons and nerve terminals. J Neurosci 1996; 16: 955-963.
11. Hu H, Shao LR, Chavoshy S, Gu N, Trieb M, Behrens R et al. Presynaptic Ca2+-activated K+ channels in glutamatergic hippocampal terminals and their role in spike repolarization and regulation of transmitter release. J Neurosci 2001; 21: 9585-9597. (Pubitemid 34184046)
12. Sailer CA, Kaufmann WA, Kogler M, Chen L, Sausbier U, Ottersen OP et al. Immunolocalization of BK channels in hippocampal pyramidal neurons. Eur J Neurosci 2006; 24: 442-454. (Pubitemid 44100336)
13. Ghatta S, Nimmagadda D, Xu X, Orourke ST. Large conductance, calcium-activated potassium channels: structural and functional implications. Pharmacol Ther 2006; 110: 103-116. (Pubitemid 43248728)
14. Gribkoff VK, Starrett Jr JE, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA et al. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med 2001; 7: 471-477. (Pubitemid 32298551)
15. Hong KW, Lee JH, Kim KY, Park SY, Lee WS. Cilostazol: therapeutic potential against focal cerebral ischemic damage. Curr Pharm Des 2006; 12: 565-573.
16. Runden-Pran E, Haug FM, Storm JF, Ottersen OP. BK channel activity determines the extent of cell degeneration after oxygen and glucose deprivation: a study in organotypical hippocampal slice cultures. Neuroscience 2002; 112: 277-288. (Pubitemid 34607012)
17. Zola-Morgan S, Squire LR, Rempel NL, Clower RP, Amaral DG. Enduring memory impairment in monkeys after ischemic damage to the hippocampus. J Neurosci 1992; 12: 2582-2596.
18. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 1982; 11: 491-498. (Pubitemid 12158810)
19. Block F, Schwarz M. Global ischemic neuronal damage relates to behavioural deficits: a pharmacological approach. Neuroscience 1998; 82: 791-803. (Pubitemid 27479618)
20. Alkayed NJ, Goto S, Sugo N, Joh HD, Klaus J, Crain BJ et al. Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke. J Neurosci 2001; 21: 7543-7550. (Pubitemid 32904953)
21. Leker RR, Shohami E. Cerebral ischemia and trauma: different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res 2002; 39: 55-73. (Pubitemid 34666986)
22. Chen L, Dai XN, Sokabe M. Chronic administration of dehydroepiandrosterone sulfate (DHEAS) primes for facilitated induction of long-term potentiation via sigma 1 (sigma1) receptor: optical imaging study in rat hippocampal slices. Neuropharmacol 2006; 50: 380-392. (Pubitemid 43184366)
23. Chen XS, Chen DH, Si JY, Tu GZ. Chemical constituents of Typhonium giganteum Engl. J Asian Nat Prod Res 2001; 3: 277-283.
24. Chi S, Qi Z. Regulatory effect of sulphatides on BKCa channels. Br J Pharmacol 2006; 149: 1031-1038. (Pubitemid 44950806)
25. Qi Z, Chi S, Su X, Naruse K, Sokabe M. Activation of a mechanosensitive BK channel by membrane stress created with amphipaths. Mol Membr Biol 2005; 22: 519-527. (Pubitemid 43030907)
26. Erxleben C, Everhart AL, Romeo C, Florance H, Bauer MB, Alcorta DA et al. Interacting effects of N-terminal variation and strex exon splicing on slo potassium channel regulation by calcium, phosphorylation, and oxidation. J Biol Chem 2002; 277: 27045-22752.
27. Nardi A, Olesen SP. BK channel modulators: a comprehensive overview. Curr Med Chem 2008; 15: 1126-1146. (Pubitemid 352002981)
28. White SH, Ladokhin AS, Jayasinghe S, Hristova K. How membranes shape protein structure. J Biol Chem 2001; 276: 32395-32398.
29. Miller B, Sarantis M, Traynelis SF, Attwell D. Potentiation of NMDA receptor currents by arachidonic acid. Nature 1992; 355: 722-725.
30. Petrou S, Ordway RW, Singer JJ, Walsh Jr JV. A putative fatty acid-binding domain of the NMDA receptor. Trends Biochem Sci 1993; 18: 41-42. (Pubitemid 23145109)
31. Maingret F, Patel AJ, Lesage F, Lazdunski M, Honore E. Lysophospholipids open the twopore domain mechano-gated K+channels TREK-1 and TRAAK. J Biol Chem 2000; 275: 10128-10133. (Pubitemid 30202065)
32. Nilius B, Owsianik G, Voets T. Transient receptor potential channels meet phosphoinositides. EMBO J 2008; 27: 2809-2816.
33. Huang CL, Feng S, Hilgemann DW. Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gb. Nature 1998; 391: 803-806. (Pubitemid 28099680)
34. Delmas P, Coste B, Gamper N, Shapiro MS. Phosphoinositide lipid second messengers: new paradigms for calcium channel modulation. Neuron 2005; 47: 179-182. (Pubitemid 41019249)
35. Schmidt D, Mackinnon R. Voltage-dependent K+channel gating voltage sensor toxin sensitivity depend on the mechanical state of the lipid membrane. Proc Natl Acad Sci USA 2008; 105: 19276-19281.
36. Kirber MT, Ordway RW, Clapp LH, Walsh Jr JV, Singer JJ. Both membrane stretch and fatty acids directly activate large conductance Ca2+-activated K+channels in vascular smooth muscle cells. FEBS Lett 1992; 297: 24-28.
37. Clarke AL, Petrou S, Walsh Jr JV, Singer JJ. Modulation of BKCa channel activity by fatty acids: structural requirements and mechanism of action. Am J Physiol 2002; 283: C1441-C1453. (Pubitemid 35178436)
38. Honore E. The neuronal background K(2P) channels: focus on TREK1. Nat Rev Neurosci 2007; 8: 251-261. (Pubitemid 46452327)
39. Valiyaveetil FI, Zhou Y, MacKinnon R. Lipids in the structure, folding and function of the KcsA K+channel. Biochemistry 2002; 41: 10771-10777. (Pubitemid 34971053)
40. Suh BC, Hille B. PIP2 is a necessary cofactor for ion channel function: how and why? Annu Rev Biophys 2008; 37: 175-195.
41. Yuan C, OConnell RJ, Jacob RFR, Mason P, Treistmank SN. Regulation of the gating of BKCa channel by lipid bilayer thickness. J Biol Chem 2007; 282: 7276-7286. (Pubitemid 47093666)
42. Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology 2008; 55: 310-318.
43. Noshita N, Lewen A, Sugawara T, Chan PH. Evidence of phosphorylation of akt and neuronal survival after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 2001; 21: 1442-1450. (Pubitemid 33120944)
44. Shibata M, Yamawaki T, Sasaki T, Hattori H, Hamada J, Fukuuchi Y et al. Upregulation of akt phosphorylation at the early stage of middle cerebral artery occlusion in mice. Brain Res 2002; 942: 1-10. (Pubitemid 34597063)
45. Ohba N, Kiryu-Seo S, Maeda M, Muraoka M, Ishii M, Kiyama H. Transgenic mouse overexpressing the Akt reduced the volume of infarct area after middle cerebral artery occlusion. Neurosci Lett 2004; 359: 159-162. (Pubitemid 38446662)
46. Zhao H, Sapolsky RM, Steinberg GK. Phosphoinositide-3-kinase/Akt survival signaling pathways are implicated in neuronal survival after stroke. Mol Neurobiol 2006; 34: 249-269.
47. Kilic E, Kilic U, Soliz J, Bassetti CL, Gassmann M, Hermann DM. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 2005; 19: 2026-2028. (Pubitemid 41759753)
48. Saito A, Narasimhan P, Hayashi T, Okuno S, Ferrand-Drake M, Chan PH. Neuroprotective role of a proline-rich Akt substrate in apoptotic neuronal cell death after stroke: relationships with nerve growth factor. J Neurosci 2004; 24: 1584-1593. (Pubitemid 38240953)
49. Meller R, Stevens SL, Minami M, Cameron JA, King S, Rosenzweig H et al. Neuroprotection by osteopontin in stroke. J Cereb Blood Flow Metab 2005; 25: 217-225. (Pubitemid 40171203)
50. Pignataro G, Meller R, Inoue K, Ordonez AN, Ashley MD, Xiong Z et al. In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: ischemic postconditioning. J Cereb Blood Flow Metab 2008; 28: 232-241. (Pubitemid 351161298)
51. Li Z, Cui S, Zhang Z, Zhou R, Ge Y, Sokabe M et al. DHEA-neuroprotection -neurotoxicity after transient cerebral ischemia in rats. J Cereb Blood Flow Metab 2009; 29: 287-296.
52. Mulcahy NJ, Ross J, Rothwell NJ, Loddick SA. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br J Pharmacol 2003; 140: 471-476. (Pubitemid 37330491)
53. Cai W, Zhu Y, Furuya K, Li Z, Sokabe M, Chen L. Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage. Neuropharmacology 2008; 55: 127-138.
54. Morris RGM. Development of a water maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984; 11: 47-60.
55. Chen L, Sokabe M. Presynaptic modulation of synaptic transmission by pregnenolone sulfate as studied by optical recordings. J Neurophysiol 2005; 94: 4131-4144. (Pubitemid 41691774)
56. Konnerth A, Obaid AL, Salzberg BM. Optical recording of electrical activity from parallel fibres and other cell types in skate cerebellar slices in vitro. J Physiol 1987; 393: 681-702. (Pubitemid 18046971)
57. Kojima S, Nakamura T, Nidaira T, Nakamura K, Ooashi N, Ito E et al. Optical detection of synaptically induced glutamate transport in hippocampal slices. J Neurosci 1999; 19: 2580-2588. (Pubitemid 29162406)
58. Dowler S, Kular G, Alessi DR. Protein lipid overlay assay. Sci STKE 2002; 2002: PL6.